Cargando…
CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead
Chimeric antigen receptor- (CAR-) T cell therapy is one of the most recent innovative immunotherapies and is rapidly evolving. Like other technologies, CAR-T cell therapy has undergone a long development process, and persistent explorations of the actions of the intracellular signaling domain and ma...
Autores principales: | Zhang, Qingyang, Ping, Jieming, Huang, Zirui, Zhang, Xiaoli, Zhou, Jingyi, Wang, Gangyang, Liu, Shaoyang, Ma, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201836/ https://www.ncbi.nlm.nih.gov/pubmed/32411789 http://dx.doi.org/10.1155/2020/1924379 |
Ejemplares similares
-
The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead
por: Jia, Shengnan, et al.
Publicado: (2022) -
Retracted: The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead
por: Healthcare Engineering, Journal of
Publicado: (2023) -
The Role of Chimeric Antigen Receptor-T Cell Therapy in the Treatment of Hematological Malignancies: Advantages, Trials, and Tribulations, and the Road Ahead
por: Rohit Reddy, Sai, et al.
Publicado: (2021) -
CAR T cells for brain tumors: Lessons learned and road ahead
por: Akhavan, David, et al.
Publicado: (2019) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
por: Soltantoyeh, Tahereh, et al.
Publicado: (2021)